Dolat Capital Market's research report on Kotak Mahindra Bank
KMB reported in line numbers with NII and PPoP growing by 17% and 29% respectively. Sequential loan growth of 4.5% YoY surprised positively. Pro-forma NPAs were higher sequentially by ~60 bps to 3.27%, with pro-forma PCR at ~61%. However, bank’s COVID related provision buffers of Rs12.8bn remain unutilized thus far. Pro forma slippages at ~Rs19bn for the quarter or 3.79% (annualized) had a disproportionate share of unsecured consumer retail loans, with 40% of incremental stress coming from this segment against its loan-book share of 6%. Total restructured portfolio (including invocations) is likely to be ~0.3% of loans and remains below industry. Excluding PL and CV segments, sequential growth was broad based including a healthy growth in corporate book of over 6.5%. ECLGS disbursements stood at Rs97bn or 4.7% of advances. The bank has a market share of 5.5% in the total industry ECLGS disbursements against KMB’s advances market share of ~2%.
Outlook
Our earnings upgrade for FY21E is largely led by decline in credit costs, while that for FY22/23E more impacted by operating efficiencies. We maintain our ACCUMULATE rating with a revised TP of Rs1,900 based on 3.9x Dec-22E ABV for the standalone bank and value of subsidiaries, implying a P/ABV of 5.0x.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.